Aptsci

Seoul, KR · 2 known investors

AptsciAptamer Science develops aptamer-based drug delivery and diagnostic platforms for precision medicine applications. The company specializes in cancer therapeutics using its proprietary ApDC (Aptamer-Drug Conjugate) technology, as well as early-stage lung cancer diagnostic kits and emerging programs in immunotherapy and metabolic disease.

BiotechDigital HealthMedical Devices